Cannara Biotech Inc (LOVE) — Cash Flow Quality Index
Cannara Biotech Inc (LOVE) has a Cash Flow Quality Index of 7.66x as of November 2025. Operating cash flow of CA$7.96 Million exceeds net income of CA$1.04 Million, indicating high earnings quality where cash backs reported profits. Explore LOVE cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cannara Biotech Inc Cash Flow Quality Index (2022–2025)
Historical Cash Flow Quality Index for Cannara Biotech Inc across 4 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see Cannara Biotech Inc cash flow conversion.
Annual Cash Flow Quality Index for Cannara Biotech Inc (2022–2025)
Year-by-year earnings quality comparison for Cannara Biotech Inc.
| Year | Quality Index | Operating CF (CAD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.53x | CA$20.01 Million | CA$13.08 Million | ▼ -7.8% |
| 2024 | 1.66x | CA$10.68 Million | CA$6.44 Million | ▲ +95.0% |
| 2023 | 0.85x | CA$5.91 Million | CA$6.95 Million | ▲ +132.3% |
| 2022 | -2.64x | CA$-6.08 Million | CA$2.31 Million | — |